✦ LIBER ✦

Long-term experience with deferasirox (ICL670), a once-daily oral iron chelator, in the treatment of transfusional iron overload

✍ Scribed by Cappellini, MD; Taher, A

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of ICL670, a Once-Daily Oral

✍ RENZO GALANELLO 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

Long-term treatment of transfusional iro

✍ M. J. Kersten; R. Lange; M. E. P. Smeets; G. Vreugdenhil; K. J. Roozendaal; W. L 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 195 KB

Reduction in labile plasma iron during t

✍ Shahina Daar; Anil Pathare; Hanspeter Nick; Ulrike Kriemler-Krahn; Abdel Hmissi; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

Long-term treatment of transfusional iro

✍ M.J. Kersten; R. Lange; M.E.P. Smeets; G. Vreugdenhil; R. Goudsmit; K.J. Roozend 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Investigation of the Pharmacokinetic Int

✍ Skerjanec, Andrej; Wang, Jixian; Maren, Kelly; Rojkjaer, Lisa 📂 Article 📅 2010 🏛 Sage Publications 🌐 English ⚖ 201 KB

54 A PHASE I/II, OPEN-LABEL, DOSE-ESCALA

✍ A. Pietrangelo; P. Brissot; H. Bonkovsky; C. Niederau; L. Rojkjaer; R. Weitzman; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB